Skip to main content
logo
Recce Pharmaceuticals Ltd (ASX:RCE)
Australia flag Australia · Delayed Price · Currency is AUD
0.3250
-0.0150 (-4.41%)
Sep 22, 2026, 3:54 PM AEST

Recce Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
9911784122111158
Market Cap Growth
-14.09%40.05%-31.67%9.86%-29.54%-2.17%
Enterprise Value
10711886121110142
Last Close Price
0.330.410.290.590.610.87

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
10.5012.3711.1424.3425.5251.25
PB Ratio
-5.94-7.00-27.40-12.85-43.0315.71
P/TBV Ratio
-----15.71

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
11.2912.4211.5124.0325.1346.16

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
-0.62-0.62-3.53-1.10-1.270.01
Net Debt / Equity Ratio
-0.45-0.45-0.03-0.64-0.67-1.14
Net Debt / EBITDA Ratio
-0.54-0.540.00-0.36-0.131.20
Net Debt / FCF Ratio
-0.75-0.750.00-0.46-0.141.27
Asset Turnover
0.900.900.801.130.570.18
Quick Ratio
0.400.401.780.300.344.81
Current Ratio
0.440.441.860.340.404.98
Return on Equity (ROE)
-----350.01%-71.89%
Return on Assets (ROA)
-82.75%-82.75%-135.80%-238.05%-106.04%-35.15%
Return on Capital Employed (ROCE)
177.90%177.90%-324.70%195.40%561.40%-94.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-15.06%-12.78%-25.62%-14.43%-11.74%-6.95%
FCF Yield
-10.02%-8.50%-24.48%-10.75%-11.42%-5.72%
Buyback Yield / Dilution
-22.02%-22.02%-33.81%-1.79%0.09%-12.05%